Cargando…
Efficacy and safety of integrated traditional Chinese and Western medicine for the treatment of infant bronchiolitis: A systematic review, meta-analysis and GRADE evaluation
BACKGROUND: Infant bronchiolitis has a high death rate in severe cases. In China, traditional Chinese medicine (TCM) is commonly used to treat infant bronchiolitis. However, it has not received enough international attention. OBJECTIVE: We aimed to assess the efficacy and safety of integrated TCM an...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333466/ https://www.ncbi.nlm.nih.gov/pubmed/35905219 http://dx.doi.org/10.1097/MD.0000000000029531 |
_version_ | 1784758882783985664 |
---|---|
author | Wang, Hao Liu, Xiaoying Wu, Yabin Yang, Chune Chen, Xiuzhen Wang, Wei |
author_facet | Wang, Hao Liu, Xiaoying Wu, Yabin Yang, Chune Chen, Xiuzhen Wang, Wei |
author_sort | Wang, Hao |
collection | PubMed |
description | BACKGROUND: Infant bronchiolitis has a high death rate in severe cases. In China, traditional Chinese medicine (TCM) is commonly used to treat infant bronchiolitis. However, it has not received enough international attention. OBJECTIVE: We aimed to assess the efficacy and safety of integrated TCM and Western medicine for treating infant bronchiolitis. METHODS: We conducted a systematic review through 7 databases that included randomized controlled trials on integrated TCM and Western medicine for treating bronchiolitis, published in English or Chinese before February 4, 2021. To assess the risk of bias, the Cochrane Collaboration tool was employed to determine the quality of the included studies. We investigated clinical efficacy endpoints, hospitalization time, rates of recurrence, and adverse reactions and meta-analyzed the odds ratio (OR), mean difference (MD), and relative risk (RR), respectively. We assessed the overall certainty of the effect estimates using the GRADE approach. This study is registered with PROSPERO (CRD42021245294). Ethical approval is not required. RESULTS: Forty-six studies (6427 children) were available for inclusion. We used 41 (5490 participants), 11 (1350 participants), 5 (1083 participants), and 11 (1295 participants) studies to analyze clinical efficacy endpoints (OR: 3.31; 95% confidence interval [CI]: 2.93, 3.74; P < .5), hospitalization time (MD: –2.10; 95% CI: –2.87, –1.34; P < .5), recurrence rate (RR: 0·41; 95% CI: 0.30, 0.56; P < .01), and adverse reaction rate (RR: 0.87; 95% CI: 0.55, 1.39; P = .57), respectively. CONCLUSIONS: Integrated TCM and Western medicine is superior to Western medicine alone for treating bronchiolitis in terms of clinical efficacy, hospitalization time, and recurrence rate, with no increase in the adverse reaction rate. TCM is useful as an alternative therapy for viral bronchiolitis. Although further studies are needed to establish specific protocols for the use of TCM in clinical practice, these results may strengthen guideline recommendations regarding the use of TCM. |
format | Online Article Text |
id | pubmed-9333466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-93334662022-08-03 Efficacy and safety of integrated traditional Chinese and Western medicine for the treatment of infant bronchiolitis: A systematic review, meta-analysis and GRADE evaluation Wang, Hao Liu, Xiaoying Wu, Yabin Yang, Chune Chen, Xiuzhen Wang, Wei Medicine (Baltimore) Research Article BACKGROUND: Infant bronchiolitis has a high death rate in severe cases. In China, traditional Chinese medicine (TCM) is commonly used to treat infant bronchiolitis. However, it has not received enough international attention. OBJECTIVE: We aimed to assess the efficacy and safety of integrated TCM and Western medicine for treating infant bronchiolitis. METHODS: We conducted a systematic review through 7 databases that included randomized controlled trials on integrated TCM and Western medicine for treating bronchiolitis, published in English or Chinese before February 4, 2021. To assess the risk of bias, the Cochrane Collaboration tool was employed to determine the quality of the included studies. We investigated clinical efficacy endpoints, hospitalization time, rates of recurrence, and adverse reactions and meta-analyzed the odds ratio (OR), mean difference (MD), and relative risk (RR), respectively. We assessed the overall certainty of the effect estimates using the GRADE approach. This study is registered with PROSPERO (CRD42021245294). Ethical approval is not required. RESULTS: Forty-six studies (6427 children) were available for inclusion. We used 41 (5490 participants), 11 (1350 participants), 5 (1083 participants), and 11 (1295 participants) studies to analyze clinical efficacy endpoints (OR: 3.31; 95% confidence interval [CI]: 2.93, 3.74; P < .5), hospitalization time (MD: –2.10; 95% CI: –2.87, –1.34; P < .5), recurrence rate (RR: 0·41; 95% CI: 0.30, 0.56; P < .01), and adverse reaction rate (RR: 0.87; 95% CI: 0.55, 1.39; P = .57), respectively. CONCLUSIONS: Integrated TCM and Western medicine is superior to Western medicine alone for treating bronchiolitis in terms of clinical efficacy, hospitalization time, and recurrence rate, with no increase in the adverse reaction rate. TCM is useful as an alternative therapy for viral bronchiolitis. Although further studies are needed to establish specific protocols for the use of TCM in clinical practice, these results may strengthen guideline recommendations regarding the use of TCM. Lippincott Williams & Wilkins 2022-07-29 /pmc/articles/PMC9333466/ /pubmed/35905219 http://dx.doi.org/10.1097/MD.0000000000029531 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | Research Article Wang, Hao Liu, Xiaoying Wu, Yabin Yang, Chune Chen, Xiuzhen Wang, Wei Efficacy and safety of integrated traditional Chinese and Western medicine for the treatment of infant bronchiolitis: A systematic review, meta-analysis and GRADE evaluation |
title | Efficacy and safety of integrated traditional Chinese and Western medicine for the treatment of infant bronchiolitis: A systematic review, meta-analysis and GRADE evaluation |
title_full | Efficacy and safety of integrated traditional Chinese and Western medicine for the treatment of infant bronchiolitis: A systematic review, meta-analysis and GRADE evaluation |
title_fullStr | Efficacy and safety of integrated traditional Chinese and Western medicine for the treatment of infant bronchiolitis: A systematic review, meta-analysis and GRADE evaluation |
title_full_unstemmed | Efficacy and safety of integrated traditional Chinese and Western medicine for the treatment of infant bronchiolitis: A systematic review, meta-analysis and GRADE evaluation |
title_short | Efficacy and safety of integrated traditional Chinese and Western medicine for the treatment of infant bronchiolitis: A systematic review, meta-analysis and GRADE evaluation |
title_sort | efficacy and safety of integrated traditional chinese and western medicine for the treatment of infant bronchiolitis: a systematic review, meta-analysis and grade evaluation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333466/ https://www.ncbi.nlm.nih.gov/pubmed/35905219 http://dx.doi.org/10.1097/MD.0000000000029531 |
work_keys_str_mv | AT wanghao efficacyandsafetyofintegratedtraditionalchineseandwesternmedicineforthetreatmentofinfantbronchiolitisasystematicreviewmetaanalysisandgradeevaluation AT liuxiaoying efficacyandsafetyofintegratedtraditionalchineseandwesternmedicineforthetreatmentofinfantbronchiolitisasystematicreviewmetaanalysisandgradeevaluation AT wuyabin efficacyandsafetyofintegratedtraditionalchineseandwesternmedicineforthetreatmentofinfantbronchiolitisasystematicreviewmetaanalysisandgradeevaluation AT yangchune efficacyandsafetyofintegratedtraditionalchineseandwesternmedicineforthetreatmentofinfantbronchiolitisasystematicreviewmetaanalysisandgradeevaluation AT chenxiuzhen efficacyandsafetyofintegratedtraditionalchineseandwesternmedicineforthetreatmentofinfantbronchiolitisasystematicreviewmetaanalysisandgradeevaluation AT wangwei efficacyandsafetyofintegratedtraditionalchineseandwesternmedicineforthetreatmentofinfantbronchiolitisasystematicreviewmetaanalysisandgradeevaluation |